293,458 Shares in AirSculpt Technologies, Inc. $AIRS Bought by Citizens Financial Group Inc. RI

Citizens Financial Group Inc. RI bought a new stake in AirSculpt Technologies, Inc. (NASDAQ:AIRS) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 293,458 shares of the company’s stock, valued at approximately $1,321,000. Citizens Financial Group Inc. RI owned 0.42% of AirSculpt Technologies as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. GSA Capital Partners LLP bought a new stake in AirSculpt Technologies in the second quarter valued at approximately $1,913,000. Flputnam Investment Management Co. bought a new position in shares of AirSculpt Technologies during the 2nd quarter worth approximately $3,114,000. Hsbc Holdings PLC bought a new position in shares of AirSculpt Technologies during the 1st quarter worth approximately $135,000. Aristides Capital LLC acquired a new position in shares of AirSculpt Technologies during the 4th quarter worth approximately $140,000. Finally, Barclays PLC increased its holdings in shares of AirSculpt Technologies by 108.9% during the 4th quarter. Barclays PLC now owns 48,843 shares of the company’s stock worth $97,000 after acquiring an additional 25,461 shares during the last quarter. Institutional investors own 91.54% of the company’s stock.

AirSculpt Technologies Stock Performance

NASDAQ AIRS opened at $2.69 on Wednesday. AirSculpt Technologies, Inc. has a 12-month low of $1.51 and a 12-month high of $12.00. The firm has a 50-day moving average price of $4.44 and a two-hundred day moving average price of $3.57. The company has a market capitalization of $193.95 million, a P/E ratio of -14.94 and a beta of 2.33. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.32.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.01). The company had revenue of $42.90 million during the quarter, compared to the consensus estimate of $44.14 million. AirSculpt Technologies had a negative net margin of 7.79% and a negative return on equity of 5.83%.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Leerink Partners set a $4.50 price objective on shares of AirSculpt Technologies in a research report on Thursday, May 14th. Wall Street Zen lowered shares of AirSculpt Technologies from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings raised shares of AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 1st. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $4.50.

AirSculpt Technologies Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.